2021
|
Invention
|
Controlled release dosage form. B receptor agonist. |
|
Invention
|
Controlled release dosage form with enhanced pharmacokinetics. B receptor agonist. |
2016
|
Invention
|
Method of administering r-baclofen in an extended release dosage form. The present invention prov... |
|
Invention
|
Controlled release oral dosage form of gaba receptor agonist. The present invention provides a si... |
|
Invention
|
Method of improving gaba-b receptor agonist therapy. The present invention provides a method of i... |
|
Invention
|
Controlled release oral dosage form of gaba receptor agonist with enhanced pharmacokinetics. The ... |
2012
|
Invention
|
Osmotic device containing amantadine and an osmotic salt. The osmotic devices of the present inve... |
2007
|
Invention
|
Controlled release dosage form containing lercanidipine and a performance-enhancing acid.
A cont... |
|
Invention
|
Ophthalmic solutions.
Aqueous ophthalmic solutions containing a combination of hyaluronic acid o... |
2006
|
Invention
|
Venlafaxine osmotic device formulation.
The present invention provides an osmotic device contain... |
|
Invention
|
Extended release solid pharmaceutical composition containing carbidopa and levodopa.
The inventi... |
|
Invention
|
Dual controlled release dosage form. A dosage form that provides a controlled release of at least... |
|
Invention
|
Controlled release device containing lercanidipine.
The present invention provides a simple and ... |
2005
|
Invention
|
Combination treatment for impaired motor function in parkinson's disease.
The invention provides... |
2004
|
Invention
|
Rupturing controlled release device having a preformed passageway. The present invention provides... |
2003
|
Invention
|
Osmotic device containing pseudoephedrine and an h1 antagonist. The present invention provides an... |
2002
|
Invention
|
Combined diffusion/osmotic pumping drug delivery system. Delivery devices capable of delivering o... |
2001
|
Invention
|
Multi-layered osmotic device. The present invention provides a simple and improved multi-layered ... |
|
Invention
|
Pharmaceutical compositions containing oxybutynin. A pharmaceutical composition and dosage form f... |
|
Invention
|
Pharmaceutical composition containing mosapride and pancreatin. A pharmaceutical composition cont... |
|
Invention
|
Pharmaceutical composition for the treatment of cognitive cerebrovascular disease. A pharmaceutic... |
|
Invention
|
Osmotic device containing alprazolam and an antipsychotic agent. The present invention provides a... |
|
Invention
|
Osmotic device containing diltiazem and an ace inhibitor or diuretic. The present invention provi... |
|
Invention
|
Osmotic device within an osmotic device. The delivery devices described herein are capable of del... |
2000
|
Invention
|
Osmotic device having a preformed passageway that increases in size. The present invention provid... |
|
Invention
|
Osmotic device containing venlafaxine and an anti-psychotic agent. The present invention provides... |